Barrier Therapeutics

BARRIER THERAPEUTICS is a pharmaceutical company focused on the discovery, development and commercialization of pharmaceutical products in the field of dermatology. Our goal is to develop a portfolio of innovative products that address major medical needs in the treatment of dermatological diseases and disorders. Our product pipeline includes marketed products and as well as product candidates in various stages of clinical development.

Contact Details: 600 College Road East, Suite 3200 Princeton 08540-6697 United States of America Tel: (609) 945-1200 Fax: (609) 945-1212 Email: WWW: www.barriertherapeutics.com/

Recent Publications by Barrier Therapeutics:
Retinoic acid metabolism blocking agents (RAMBAs): a new paradigm in the treatment of hyperkeratotic disorders. Synthetic vitamin A derivatives, retinoids,have long been the mainstay of...	30th May, 2008	Barrier Therapeutics NV, Geel, Belgium, and Department of Dermatology,	J Dtsch Dermatol Ges. 2008 May;6(5):355-64. Epub 2007 Oct 16. DOI Direct Link
The role of ketoconazole in seborrheic dermatitis. Although the prominent broad-spectrum activity of ketoconazole was...	28th February, 2008	Barrier Therapeutics NV, Geel, Belgium.	Cutis. 2007 Oct;80(4):359-63.
Absence of an active metabolite for the triazole antifungal pramiconazole. Pramiconazole is an antifungal with high potential for the treatment of...	30th May, 2007	Barrier Therapeutics NV, Cipalstraat 3, Geel, Belgium.	Acta Derm Venereol. 2007;87(1):22-6. DOI Direct Link
Fungal infections of the skin: infection process and antimycotic therapy. Dermatomycoses are among the most widespread and common superficial and...	8th February, 2006	Barrier Therapeutics, Cipalstraat 3, 2440 Geel, Belgium.	Curr Drug Targets. 2005 Dec;6(8):849-62.

Press Releases on Barrier Therapeutics:
Stiefel Laboratories Reaps First Fruits of Barrier Acquisition With Completion of Pivotal Phase III Clinical Trial for 200 mg Hyphanox(TM) (Itraconazole) Tablet	2nd June, 2009	Stiefel Laboratories, Inc.	CORAL GABLES, Fla., June 2 /PRNewswire/ -- Stiefel Laboratories, Inc. announced the completion and analysis of a pivotal phase III clinical trial for Hyphanox(TM) (itraconazole) tablet. The 200 mg
RHEI Pharmaceuticals Appoints Dr. Geert Cauwenbergh as Chief Executive Officer	25th August, 2008	RHEI Pharmaceuticals, Inc.	NEW HAVEN, Conn., Aug. 25 /PRNewswire/ -- RHEI Pharmaceuticals, Inc. today announced the appointment of Dr. Geert Cauwenbergh as Chief Executive Officer. Dr. Cauwenbergh succeeds Joos Horsten, who
Stiefel Laboratories Completes Acquisition of Barrier Therapeutics	6th August, 2008	Stiefel Laboratories, Inc.	CORAL GABLES, Fla., Aug. 6 /PRNewswire/ -- Stiefel Laboratories, Inc., the world's largest independent pharmaceutical company specializing in dermatology, announced today that it has
Stiefel Laboratories, Inc. Successfully Completes Tender Offer for Shares of Barrier Therapeutics, Inc.	5th August, 2008	Stiefel Laboratories, Inc.	CORAL GABLES, Fla., Aug. 5 /PRNewswire/ -- Stiefel Laboratories, Inc. ("Stiefel Laboratories"), the world's largest independent pharmaceutical company specializing in dermatology,
Stiefel Laboratories, Inc. Announces Expiration of Hart-Scott-Rodino Waiting Period Relating to its Proposal to Acquire Barrier Therapeutics, Inc.	29th July, 2008	Stiefel Laboratories, Inc.	CORAL GABLES, Fla., July 29 /PRNewswire/ -- Stiefel Laboratories, Inc. ("Stiefel Laboratories"), the world's largest independent pharmaceutical company specializing in dermatology,

BioNews Results for Barrier Therapeutics:
Discovery Of Potential Pancreatic Cancer Treatment	Drug Discovery and Development:  Nov 6 2009 1:51AM Matching: barrier therapeutics
Medical News: Discovery Offers Potential New Pancreatic Cancer Treatment	Medical News Today:  Nov 3 2009 4:46PM Matching: barrier therapeutics
Pancreatic Cancer: Discovery Offers Potential New Treatment	Science Daily:  Nov 3 2009 4:46AM Matching: barrier therapeutics
Discovery Offers Potential New Pancreatic Cancer Treatment	Medical News Today:  Nov 3 2009 4:47PM Matching: barrier therapeutics
Tumor-penetrating microparticles may offer treatment hope for those suffering with pancreatic cancer	News-Medical.Net:  Nov 3 2009 9:15AM Matching: barrier therapeutics
Promote your company here: BioNewsCast - Press Release Distribution	→View more Barrier Therapeutics news.

Barrier Therapeutics Clinical Trials:
Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants

Barrier Therapeutics (BTRX) Financial information Links from Barchart
BTRX Quote from from Barchart.com
BTRX Chart from from Barchart.com
BTRX Profile from from Barchart.com
BTRX Opinion from from Barchart.com
→View more Barrier Therapeutics finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 664 times since April 2007, the link to the organisation's website has been followed 100 times

Recent Search Terms used to find this page: barrier therapeutics | barrier therapeutics | Barrier Therapeutics | barrier therapeutics en geert cauwenbergh | barrier therapeutics en geert cauwenbergh | pramiconazole stiefel clinical | BARRIER THERAPEUTICS | barrier therapeutics and FLA compan | geert cauwenbergh barrier therapeutics | barrier therapeutics | .

Search for more companies in Princeton

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Barrier Therapeutics